Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Norway

Norway: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 95.0% in 2025. ▬ Flat

Latest (2025)
95.0%
Change on year
up 1.1%
World rank
29th
of 194 countries
All-time high
97.0%
in 2010
All-time low
89.0%
in 2003
Years of data
26
2000–2025

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Norway, 2000–2025

0204060801002000201220252000: 902001: 902002: 902003: 892004: 902005: 912006: 912007: 932008: 952009: 962010: 972011: 942012: 912013: 912014: 922015: 912016: 912017: 912018: 932019: 952020: 952021: 952022: 942023: 942024: 942025: 95

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Norway is 95.0%, measured in 2025.

Compared with earlier readings it is up 1.1% on the previous year and up 4.4% over ten years.

Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Norway peaked at 97.0% in 2010 and was at its lowest, 89.0%, in 2003.

That places Norway 29th out of 194 countries with data for 2025, putting it in the top quarter.

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Norway, year by year

Annual values for Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC) in Norway, 2000 to 2025.
Year Value Change
2000 90.0% —
2001 90.0% +0.0%
2002 90.0% +0.0%
2003 89.0% -1.1%
2004 90.0% +1.1%
2005 91.0% +1.1%
2006 91.0% +0.0%
2007 93.0% +2.2%
2008 95.0% +2.2%
2009 96.0% +1.1%
2010 97.0% +1.0%
2011 94.0% -3.1%
2012 91.0% -3.2%
2013 91.0% +0.0%
2014 92.0% +1.1%
2015 91.0% -1.1%
2016 91.0% +0.0%
2017 91.0% +0.0%
2018 93.0% +2.2%
2019 95.0% +2.2%
2020 95.0% +0.0%
2021 95.0% +0.0%
2022 94.0% -1.1%
2023 94.0% +0.0%
2024 94.0% +0.0%
2025 95.0% +1.1%

Norway compared with similar countries

  • Norway's 95.0% is above the median for high income countries, which is 92.0%, 1.0× the median. (63 countries reporting)
  • Norway's 95.0% is above the median for Europe & Central Asia, which is 90.0%, 1.1× the median. (51 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 91.5% 89.0% 96.0% 10
2010s 92.6% 91.0% 97.0% 10
2020s 94.5% 94.0% 95.0% 6

Countries ranked near Norway

  1. 26 Trinidad and Tobago 96.0% compare
  2. 26 Andorra 96.0% compare
  3. 26 Egypt 96.0% compare
  4. 29 India 95.0% compare
  5. 29 Uruguay 95.0% compare
  6. 29 Mongolia 95.0% compare
  7. 29 Japan 95.0% compare
  8. 29 Vietnam 95.0% compare
  9. 29 South Korea 95.0% compare
  10. 29 Portugal 95.0% compare
  11. 29 Russia 95.0% compare
  12. 29 Armenia 95.0% compare
  13. 29 Tuvalu 95.0% compare
  14. 29 Sri Lanka 95.0% compare
  15. 29 United States 95.0% compare
  16. 29 Nicaragua 95.0% compare

See the full ranking of 207 places →

More health data for Norway

All data for Norway →

Frequently asked questions

What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Norway?
Measles-containing-vaccine second-dose (mcv2) immunization coverage in Norway was 95.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Norway?
The highest recorded value was 97.0% in 2010.
What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Norway?
The lowest recorded value was 89.0% in 2003.
How does Norway rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
Norway ranks 29th out of 194 countries with data for 2025.
Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Norway?
Over the last ten years it is up 4.4%. The long-run trend across the full record is flat.
Where does this Norway data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Norway. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 October 2026, from https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/norway/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/norway/">Measles-containing-vaccine second-dose (MCV2) immunization coverage in Norway</a> — Statizoid

About this data

Indicator
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 5,363 data points, 2000–2025
Last refreshed